Top Markets
Coin of the day
Apollo Endosurgery, Inc. Apollo Endosurgery, Inc.

Apollo Endosurgery, Inc.

APEN
株式のランク #18059
Apollo Endosurgery, Inc. is a medical technology firm specializing in the... Apollo Endosurgery, Inc. is a medical technology firm specializing in the creation, development, and commercialization of advanced medical instruments. Among its products are the OverStitch and OverStitch Sx Endoscopic Suturing Systems, which empower physicians to perform advanced endoscopic procedures by suturing and securing tissue approximation via a flexible endoscope. The company also features the Orbera intragastric balloon system, available under brands such as Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System. This system aids in weight management by decreasing stomach capacity and slowing gastric emptying, thereby encouraging reduced food intake. Additionally, it provides the X-Tack Endoscopic HeliX Tacking System, a suture-based device designed for repairing defects in both the upper and lower gastrointestinal tract. Its medical solutions are distributed to various healthcare providers, including hospitals, outpatient surgical centers, clinics, and individual physicians, across the United States, Australia, Costa Rica, and several European nations. Founded in 2005, Apollo Endosurgery, Inc. maintains its headquarters in Austin, Texas.
株価
$10.00
最終同期: 2023-04-11
時価総額
$214.01M
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Apollo Endosurgery, Inc. (APEN)

カテゴリー

Apollo Endosurgery, Inc.(APEN)の配当利回りの履歴
Apollo Endosurgery, Inc.(銘柄コード: APEN)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Apollo Endosurgery, Inc.(APEN)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)